Saturday, May 8, 2021
wellness India Expo
Home Tags Takeda

Tag: Takeda

World Hemophilia Day: Takeda reiterates commitment to supporting patients

The pharma major has partnered with sand artist Padma, Sudarshan Pattnaik to drive awareness on World Hemophilia Day....................

Takeda launches mobile application to support patient for treatment of genetic...

The XPERT EASE App will support HCPs with dose calculation for the treatment of patients with Lysosomal Storage Disorders............

Takeda strengthens patient offering in India via availability of Kynteles

Takeda Pharma has introduced innovative Gastrointestinal portfolio for patients with Inflammatory Bowel Diseases (IBD) and Ulcerative Colitis and Crohn's Disease. Kynteles is likely to benefit patients with a low risk of serious or opportunistic infections like Tuberculosis...................

Takeda India contributes ₹1.2 Crore to COVID-19 PM Cares Fund

The contribution to the PM Cares Fund aims to support patients and the Government to contain the spread of the disease.................

World Hemophilia Day: Takeda India stands united for hemophilia patients

While approximately 21,000 hemophilic patients are registered in India, the ongoing government support, standards of care have improved in the country......................

Takeda appoints new country head for India

Seasoned biopharmaceutical leader with over 17 years of experience across geographies, Koki Sato to lead Takeda’s business in India, ensuring patient access to highly innovative medicines.......................

Takeda initiates development of a plasma-derived therapy for COVID-19

Exploring the potential to repurpose marketed products and molecules, the company is developing Anti-SARS-CoV-2 polyclonal hyperimmune globulin (H-IG) to treat infected, high-risk individuals with COVID-19...................

Takeda appoints Dr Mahender Nayak as new Area Head for India

Proven leader with more than 20 years of experience in the biopharmaceutical industry, Dr Mahender Nayak will continue to increase patient access to Takeda’s portfolio of highly innovative medicines..................

Takeda expands India portfolio of rare disease therapies

The company has launched Enzyme Replacement Therapy bouquet for Lysosomal Storage Disorders (LSD), Idursulfase for Hunter Syndrome, Velaglucerase Alpha for Gaucher Disease and Agalsidase Alfa for Fabry Disease..........................

Takeda announces Andrey Potapov as ICMEA Area Head

Potapov’s appointment follows Takeda’s recent acquisition of Shire Pharmaceuticals – enabling Takeda to become a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan...............